Dr. Jason Diamond, the celebrity plastic surgeon behind Metacine, has launched LipLift, a $120 treatment designed to address lip aging through volumization. The product arrives as the second release in The Contour Collection, following April's debut of EyeLift Bioremodeling Peptide Multiplex.
LipLift targets a specific concern: lips that lose definition and volume with age. The treatment uses a peptide-driven formula to restore fullness without injection, positioning itself as an alternative to traditional lip augmentation procedures. At $120, it sits at a mid-range price point for at-home lip treatments, competing directly with brands like Estée Lauder's Advanced Night Repair and Augustinus Bader's lip care offerings.
Diamond's Metacine line focuses on bioremodeling technology, a term gaining traction in prestige skincare. Bioremodeling emphasizes cellular regeneration over surface-level hydration, using peptides and targeted actives to encourage the skin's natural repair mechanisms. This approach appeals to consumers skeptical of invasive procedures but seeking clinical-grade results.
The expansion of The Contour Collection reveals Diamond's strategy. By launching coordinated treatments for different facial areas, he creates an ecosystem encouraging consumers to build routines. EyeLift preceded LipLift by several months, establishing the collection's anti-aging focus around delicate zones prone to visible aging.
The product launches reflect broader industry trends. Prestige skincare increasingly targets specific face zones with specialized formulations rather than offering one-size-fits-all serums. Brands like SK-II and La Mer have adopted similar zonal approaches, recognizing that consumers want precision over generalization.
Diamond's celebrity status as a cosmetic surgeon lends credibility to Metacine's claims. His surgical background informs the product development,